- Home
- / Appello Pharmaceuticals
Appello Pharmaceuticals
Total Funding
$10.5 M
Appello Pharmaceuticals Summary
Company Summary
- Overview
- Appello Pharmaceuticals is a preclinical-stage company that discovers and develops novel positive allosteric modulators for the treatment of Parkinson's disease.
- Type
- Private
- Status
- Active
- HQ
- Nashville, TN, US | view all locations
- Website
- https://appellopharma.com/
- Cybersecurity rating
Table of Contents
Key People
Joann Scatina, Director
Brian Laden, President & CEO
Ian Hardy, Vice President for Chemistry
LocationsView all
1 location detected
Nashville, TN HQ
United States
Nashville, TN, USA